The need for levodopa as an end point of
✍
Dr. Peter LeWitt; David Oakes; Lu Cui
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 693 KB
## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th